Production and characterization of protective human antibodies against Shiga toxin 1

Infection and Immunity

Volumn 70, Issue 10, 2002, Pages 5896-5899

  Mukherjee, Jean ^a   Chios, Kerry ^a   Fishwild, Dianne ^a   Hudson, Deborah ^a   O'Donnell, Susan ^a   Rich, Stephen M ^a   Donohue Rolfe, Arthur ^a   Tzipori, Saul ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 10F4; MONOCLONAL ANTIBODY 14C9; MONOCLONAL ANTIBODY 14H3; MONOCLONAL ANTIBODY 15G2; MONOCLONAL ANTIBODY 15G9; MONOCLONAL ANTIBODY 1B10; MONOCLONAL ANTIBODY 2D9; MONOCLONAL ANTIBODY 5A4; MONOCLONAL ANTIBODY 7E12; MONOCLONAL ANTIBODY 8A5; NEUTRALIZING ANTIBODY; SHIGA TOXIN; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY ISOLATION; ANTIBODY PRODUCTION; ARTICLE; BETA CHAIN; CONTROLLED STUDY; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOTHERAPY; IN VITRO STUDY; INTOXICATION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SURVIVAL RATE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; CHILD; ESCHERICHIA COLI; FEMALE; HELA CELLS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; HYBRIDOMAS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; NEUTRALIZATION TESTS; SHIGA-LIKE TOXIN I;

EID: 0036784674     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.10.5896-5899.2002     Document Type: Article

References (28)

1. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies
2. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies
3. Antibody-based protection of gnotobiotic piglets infected with Escherichia coli O157:H7 against systemic complications associated with Shiga toxin 2
4. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies
5. Animal toxicity of Shigella dysenteriae cytotoxin: Evidence that the neurotoxic, enterotoxic, and cytotoxic activities are due to one toxin
6. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins
7. Monoclonal antibody strategy and techniques
8. High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice
9. Effects of Escherichia coli Shiga-like toxins (verotoxins) in pigs
10. Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum
11. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome
12. Production and characterization of monoclonal antibodies with therapeutic potential against Shiga toxin
13. Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933
14. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli
15. Shiga toxin: Production and purification
16. Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea
17. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection
18. Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance
19. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections
20. Production and characterisation of monoclonal antibodies to Verotoxins 1 and 2 from Escherichia coli of serotype O157:H7
21. Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: A two-year prospective study
22. Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay
23. Haemolytic anaemia after childhood Escherichia coli O157:H7 infection: Are females at increased risk?
24. Solution structure of the complex between the B-subunit homopentamer of verotoxin VT-1 from Escherichia coli and the trisaccharide moiety of globotriaosylceramide
25. Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli
26. Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli
27. The immobilization of immunoreactants on solid-phases
28. Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide